Skip to main content
Premium Trial:

Request an Annual Quote

State Street Takes 5.1 Percent Stake in Applied Biosystems

NEW YORK (GenomeWeb News) – Boston-based State Street Bank and Trust disclosed in a filing with the US Securities and Exchange Commission that it now holds a 5.1 percent stake in Applied Biosystems.
 
According to Monday’s filing, State Street owns 8,590,589 shares of ABI’s stock. The bank said in the filing that the shares “were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer.”
 
Last week, investment firm SAC Capital Advisors disclosed in an SEC filing that it had increased its stake in ABI to 5.1 percent and encouraged ABI’s board of directors to explore strategic alternatives for the firm including a possible sale.
 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.